FNBP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.39408534400354E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.88939983050795E-10 |
Normal-vs-Stage2 |
7.62200000000712E-05 |
Normal-vs-Stage3 |
9.385199950529E-09 |
Normal-vs-Stage4 |
1.29559999995088E-06 |
Stage1-vs-Stage2 |
4.088200E-01 |
Stage1-vs-Stage3 |
2.323600E-01 |
Stage1-vs-Stage4 |
4.307200E-01 |
Stage2-vs-Stage3 |
9.476200E-01 |
Stage2-vs-Stage4 |
9.069000E-01 |
Stage3-vs-Stage4 |
8.275600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.30102611911798E-12 |
Normal-vs-AfricanAmerican |
6.05680000043129E-07 |
Normal-vs-Asian |
2.841000E-03 |
Caucasian-vs-AfricanAmerican |
1.361190E-01 |
Caucasian-vs-Asian |
7.678800E-03 |
AfricanAmerican-vs-Asian |
5.295700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.13239972954204E-10 |
Normal-vs-Female |
4.19109191795997E-13 |
Male-vs-Female |
6.052300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.240200E-02 |
Normal-vs-Age(41-60Yrs) |
2.02504679691629E-13 |
Normal-vs-Age(61-80Yrs) |
2.9444999771755E-09 |
Normal-vs-Age(81-100Yrs) |
1.258170E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.282400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.692000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.012200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.430560E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.109800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.089600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.33600019935898E-10 |
Normal-vs-Grade 2 |
2.08160155779069E-11 |
Normal-vs-Grade 3 |
2.15800000091804E-09 |
Normal-vs-Grade 4 |
1.53494999999282E-05 |
Grade 1-vs-Grade 2 |
8.312300E-02 |
Grade 1-vs-Grade 3 |
2.896300E-02 |
Grade 1-vs-Grade 4 |
7.936300E-02 |
Grade 2-vs-Grade 3 |
3.909800E-01 |
Grade 2-vs-Grade 4 |
8.893200E-01 |
Grade 3-vs-Grade 4 |
6.293200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7611023750419E-11 |
Normal-vs-ccB subtype |
6.30459999761968E-08 |
ccA subtype-vs-ccB subtype |
3.912600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.03600461542896E-11 |
Normal-vs-N1 |
1.058190E-01 |
N0-vs-N1 |
4.767200E-01 |
|
|